ClinicalTrials.gg
DrugSupplement

Carnitine clinical trials

Also written Carnitor.

Includes 33 studies of Acetylcarnitine.

studies test it
147
open now
18
in phase 3
33
first study started
1997

How each study uses Carnitine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Carnitine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
27 Dec 1985 · CARNITOR · NDA 018948 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

L-carnitine
57
Levocarnitine
17
Carnitine
8
L Carnitine
4
Levocarnitine Injection
3

Brand

Carnitor
9

In one entry with another drug

Given together, or one or the other

Valproic Acid and Levocarnitine
2

Studies by the year they started

145 studies that test it; most in 2016 (13)

Studies that test Carnitine, by start year
YearStudies
19971
20025
20031
20043
20052
20065
20083
20096
20109
20114
20125
201311
20144
20156
201613
20177
20189
20191
20205
20214
20227
202312
20244
202512
20266

By phase

A phase 1/2 study counts in both.

Early Phase 1
8
Phase 1
9
Phase 2
46
Phase 3
33
Phase 4
19
No phase
46

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 11 · Other 136

Ain Shams University (9) · University of Catania (6) · Tanta University (4) · Khyber Medical University Peshawar (3) · Tehran University of Medical Sciences (3) · Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh (3) · Gdansk University of Physical Education and Sport (3) · Mario Negri Institute for Pharmacological Research (3)

Often tested with

Tested in the same studies.

Thioctic Acid (4) · Acetylcysteine (4) · Valproic Acid (3) · Leucine (2) · Metformin (2) · Atorvastatin (2) · PDE5 inhibitors (2) · Calaspargase pegol (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 6, 1 in phase 3

Studies that test Carnitine, phase 3 first.

Studies

Open first, then newest update. How each study uses Carnitine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 147

See all 147 studies that test Carnitine →

Given beside what is tested · 3 — Carnitine is usual care or a partner of the new treatment
As the comparator · 3 — what is tested is compared with Carnitine

Codes

What other systems call Carnitine · ClinicalTrials.gg INT007155

  • MeSH (NLM) D002331CarnitineConfirmed NLM, Wikidata
  • UNII (FDA) 0G389FZZ9MLEVOCARNITINEConfirmed FDA, NLM, Wikidata
  • RxNorm 42955Confirmed FDA, Wikidata
  • Wikidata Q20735709L-carnitineConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C26657LevocarnitineOne source FDA
  • DrugBank DB00583One source Wikidata

Also registered as dl-carnitine (UNII S7UI8SM58A · RxNorm 2106).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.